| Literature DB >> 22454665 |
Wolf E Mehling1, E Anne Lown, Christopher C Dvorak, Morton J Cowan, Biljana N Horn, Elizabeth A Dunn, Michael Acree, Donald I Abrams, Frederick M Hecht.
Abstract
Background. Pediatric hematopoietic cell transplant (HCT) is a lifesaving treatment that often results in physical and psychological discomfort. An acupressure-massage intervention may improve symptom management in this setting. Methods. This randomized controlled pilot trial compared a combined massage-acupressure intervention to usual care. Children were offered three practitioner-provided sessions per week throughout hospitalization. Parents were trained to provide additional acupressure as needed. Symptoms were assessed using nurses' reports and two questionnaires, the behavioral affective and somatic experiences scale and the Peds quality of life cancer module. Results. We enrolled 23 children, ages 5 to 18. Children receiving the intervention reported fewer days of mucositis (Hedges' g effect size ES = 0.63), lower overall symptom burden (ES = 0.26), feeling less tired and run-down (ES = 0.86), having fewer moderate/severe symptoms of pain, nausea, and fatigue (ES = 0.62), and less pain (ES = 0.42). The intervention group showed trends toward increasing contentness/serenity (ES = +0.50) and decreasing depression (ES = -0.45), but not decreased anxiety (ES = +0.42). Differences were not statistically significant. Discussion. Feasibility of studying massage-acupressure was established in children undergoing HCT. Larger studies are needed to test the efficacy of such interventions in reducing HCT-associated symptoms in children.Entities:
Year: 2012 PMID: 22454665 PMCID: PMC3292254 DOI: 10.1155/2012/450150
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Patient characteristics.
| Intervention | Control | |
|---|---|---|
|
| 16 | 7 |
| Demographics | ||
| Age (mean) (range 5–18) | 11.3 | 13.9 |
| Sex | ||
| Female | 7 | 3 |
| Male | 9 | 4 |
| Ethnicity | ||
| White | 9 | 2 |
| Asian | 3 | 5 |
| Hispanic | 3 | 0 |
| Other | 1 | 0 |
| Diagnoses | ||
| Congenital or acquired Bone marrow failure | 5 | 0 |
| Hematologic malignancy | 6 | 5 |
| Congenital immune deficiency | 3 | 1 |
| Solid tumor | 2 | 0 |
| Hemoglobinopathy | 0 | 1 |
| Transplant type | ||
| Autologous | 13 | 6 |
Figure 1Participant flow chart.
(a) Symptoms from the nurses records over 29 days (7 days before to 21 days after transplant). Intervention (I; N = 16) versus control (C; N = 7).
| Symptom (scale range) | Arm | Mean ± SD | ES |
|
|
| ||||
| Days of pain > 3 (on 0–10 scale) | I | 7.8 ± 4.9 | 0.04 | 0.93 |
| Days of vomiting | I | 5.7 ± 4.6 | 0.11 | 0.82 |
| Days of mucositis | I | 9.9 ± 7.1 | 0.63 | 0.18 |
| Immune recovery | I | 17.1 ± 5.1 | 0.12 | 0.85 |
| Days with high symptom burden (pain > 3, nausea, mucositis, and vomiting) | I | 1.8 ± 0.5 | 0.26 | 0.57 |
(b) Symptoms from child self-report: at baseline and 1 week after transplant. Intervention (I; N = 15) versus control (C; N = 7).
| Symptom (scale range) | Arm | Mean ± SD | ES |
| |
| Before | After | ||||
|
| |||||
| Nausea and vomiting | I | 0.3 ± 0.7 | 2.3 ± 1.5 | +0.01 | 0.98 |
| Loss of appetite | I | 1.3 ± 0.7 | 2.8 ± 1.5 | +0.36 | 0.44 |
| Feeling tired/run down | I | 1.5 ± 1.3 | 1.9 ± 1.3 | +0.86 | 0.08 |
| Pain | I | 0.8 ± 1.0 | 1.2 ± 1.2 | +0.42 | 0.37 |
| Summary score of 3 moderate/severe symptoms of fatigue, pain, and nausea | I | 0.3 ± 0.4 | 1.1 + 1.1 | +0.62 | 0.23 |
¹Higher score: worse symptoms.
*ES: standardized effect sizes (“+” ES is advantage for intervention; “−” ES is advantage for control).
°t-test.
SD: standard deviation.
**Sum of moderate or severe (“quite a bit/very much” versus “none/a little/somewhat”) symptoms of fatigue, nausea, and pain, 1 week self-report (range: 0–3 symptoms).
All measures were from the BASES questionnaire except pain was measured using the Peds quality of life scale.
(a) Changes in negative affect from baseline to 1 week after transplant. Mean “+” change indicates worsening; mean “−” change indicates improvement; ES “−” indicates benefit for intervention compared with control; ES “+” vice versa.
| Symptom change (scale range) | Arm | Means ±SD | ES |
| ||
| Before | After | Change | ||||
|
| ||||||
| Depression | I | 0.7 ± 0.9 | 0.9 ± 1.1 | +0.2 ± 1.1 | −0.45 | 0.33 |
| Anxiety | I | 0.9 ± 1.0 | 0.6 ± 1.0 | −0.3 ± 0.9 | +0.42 | 0.37 |
| Worry | I | 1.4 ± 1.1 | 1.4 ± 1.2 | −0.0 ± 1.2 | +0.32 | 0.50 |
| Complaining/demanding | I | 2.4 ± 1.5 | 2.1 ± 1.0 | −0.3 ± 1.7 | −0.45 | 0.21 |
(b) Changes in positive affect and sleep quality from baseline to 1 week after transplant. Mean “+” change indicates improving; mean “−” change indicates worsening; ES “+” indicates benefit for intervention compared with control; ES “−” vice versa.
| Symptom change (scale range) | Arm | Means ±SD | ES |
| ||
| Before | After | Change | ||||
|
| ||||||
| Contentness/serenity² (0–4) | I | 2.3 ± 1.4 | 2.2 ± 1.5 | −0.1 ± 1.6 | +0.50 | 0.29 |
| Overall mood² (0–4) | I | 2.8 ± 0.9 | 2.3 ± 0.9 | −0.4 ± 1.2 | +0.20 | 0.72 |
| Sleep³ (0–4) | I | 2.7 ± 1.1 | 2.4 ± 1.3 | −0.3 ± 0.8 | −0.96 | 0.05 |
¹ Higher score: worse negative affect.
² Higher score: higher positive affect.
³ Higher score: better sleep.
* ES: standardized effect sizes.
°t-test.
I: intervention, C: control.
SD: Standard Deviation.
(Sample N for intervention (I) versus control (C); intention to treat: 15 versus 7).